Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-22

FDA Approved: OXCARBAZEPINE — Original Application (Ingenus Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved the original application for a generic oxcarbazepine product from Ingenus Pharmaceuticals, enabling marketing of the generic anticonvulsant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxcarbazepine (Oxcarbazepine)

Snippet

ORIG AP for OXCARBAZEPINE (OXCARBAZEPINE)